Surmodics reported $3.43M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Align Technology USD 260.87M 77.03M Dec/2025
Anika Therapeutics USD 4.54M 3.67M Dec/2025
Arrowhead Research USD 57.17M 7.03M Dec/2025
Artivion USD 22.72M 1.84M Dec/2025
Baxter International USD -447M 873M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Haemonetics USD 94.78M 20.75M Dec/2025
Heron Therapeutics USD -3.88M 5.63M Sep/2024
J&J USD 7.19B 2.32B Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Nektar Therapeutics USD -31.81M 70K Sep/2023
Option Care Health USD 104.77M 21.23M Mar/2026
Stryker USD 1.57B 618M Mar/2026
Surmodics USD 3.43M 1.9M Jun/2025
Trinity Biotech USD -9.6M 7.64M Dec/2024